Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis

Published:2018-11-27 Issue:1 Volume:37 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Lu Guanming,Li Yueyong,Ma Yanfei,Lu Jinlan,Chen Yongcheng,Jiang Qiulan,Qin Qiang,Zhao Lifeng,Huang Qianfang,Luo Zhizhai,Huang Shiqing,Wei Zhongheng

Funder

National Natural Science Foundation of China

Guangxi Provincial Education Department Funding

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-018-0945-6.pdf

Reference36 articles.

1. Roumeliotis GA, Dostaler G, Boyd KU. Complementary and Alternative medicines and patients with breast Cancer: a case of mortality and systematic review of patterns of use in patients with breast Cancer. Plast Surg (Oakv). 2017;25:275–83.

2. Williams AD, Payne KK, Posey AD Jr, Hill C, Conejo-Garcia J, June CH, Tchou J. Immunotherapy for breast Cancer: current and future strategies. Curr Surg Rep. 2017;5:899–905.

3. Cagel M, Bernabeu E, Gonzalez L, Lagomarsino E, Zubillaga M, Moretton MA, Chiappetta DA. Mixed micelles for encapsulation of doxorubicin with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines versus Doxil((R)). Biomed Pharmacother. 2017;95:894–903.

4. Fan S, Yang Z, Ke Z, Huang K, Liu N, Fang X, Wang K. Downregulation of the long non-coding RNA TUG1 is associated with cell proliferation, migration, and invasion in breast cancer. Biomed Pharmacother. 2017;95:1636–43.

5. Shafei A, El-Bakly W, Sobhy A, Wagdy O, Reda A, Aboelenin O, Marzouk A, El Habak K, Mostafa R, Ali MA, Ellithy M. A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer. Biomed Pharmacother. 2017;95:1209–18.

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction of noncoding RNAs with hippo signaling pathway in cancer cells and cancer stem cells;Non-coding RNA Research;2024-12

2. Beyond the Genome: Deciphering the Role of MALAT1 in Breast Cancer Progression;Current Genomics;2024-10

3. Correlative expression of exosomal miRNAs in chemotherapy resistance of triple-negative breast cancer: An observational study;Medicine;2024-08-30

4. The emerging roles of LINC00511 in breast cancer development and therapy;Frontiers in Oncology;2024-08-14

5. Competing endogenous RNAs regulatory crosstalk networks: The messages from the RNA world to signaling pathways directing cancer stem cell development;Heliyon;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3